longbridge

Wedbush Sticks to Their Buy Rating for Immunome (IMNM)

Tip Ranks
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Wedbush analyst maintained a Buy rating on Immunome today and set a price target of $35.00.Claim 55% Off TipRanks Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks Currently, the analyst consensus on Immunome is a Strong Buy with an average price target of $36.00.

Wedbush analyst maintained a Buy rating on Immunome today and set a price target of $35.00.

Claim 55% Off TipRanks

  • Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
  • Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

Currently, the analyst consensus on Immunome is a Strong Buy with an average price target of $36.00.

Source: Tip Ranks The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

© 2026 Longbridge｜Terms of ServicePrivacy Policy